« View all News

Join our Free Webinar on Pre-Clinical Considerations for TB Regimens – September 11 & 12, 2017

The TB drug development community is collectively working towards the goal of advancing entirely novel TB drug regimens containing new and existing antibiotic agents.  Agreement upon the most informative translational roadmap (including preclinical models and supporting datasets) to inform the selection of components for such a regimen, as well as, appropriate dose and rank ordering will be key enablers for this process.

While the primary goal of the workshop is to develop a roadmap to guide advancement of entirely novel regimens, we will also discuss how the principles of a rigorous, data-driven roadmap can contribute to the development of treatment courses that may include sequential combinations of existing and emerging drugs to lead to shorten treatment duration.



« View all News